1.

Record Nr.

UNINA9910790236703321

Autore

Farrell Anne-Maree <1964->

Titolo

The politics of blood : ethics, innovation, and the regulation of risk / / Anne-Maree Farrell [[electronic resource]]

Pubbl/distr/stampa

Cambridge : , : Cambridge University Press, , 2012

ISBN

1-139-41099-7

1-107-22322-9

1-280-68282-5

1-139-41303-1

9786613659767

1-139-41927-7

1-139-04796-5

1-139-42131-X

1-139-41722-3

1-139-42336-3

Descrizione fisica

1 online resource (xviii, 264 pages) : digital, PDF file(s)

Collana

Cambridge bioethics and law ; ; 17

Classificazione

LAW093000

Disciplina

362.17/84

Soggetti

Blood banks - Government policy

Blood products - Safety measures

Blood - Moral and ethical aspects

Blood - Social measures

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Title from publisher's bibliographic system (viewed on 05 Oct 2015).

Nota di bibliografia

Includes bibliographical references and index.

Nota di contenuto

1. Introduction; 2. The governance of the blood system; 3. Revisiting the gift relationship; 4. Professional beliefs and scientific expertise; 5. Risk and innovation; 6. The rise of the recipient; 7. The politics of precaution; 8. Regulating risk; 9. Conclusion.

Sommario/riassunto

How best to manage risk involving multi-valued human biological materials is the overarching theme of this book, which draws on the sourcing and supply of blood as a case study. Blood has ethical, social, scientific and commercial value. This multi-valuing process presents challenges in terms of managing risk, therefore making it ultimately a matter for political responsibility. This is highlighted through an



examination of the circumstances that led to HIV blood contamination episodes in the US, England and France, as well as their consequences. The roles of scientific expertise and innovation in managing risks to the blood system are also analysed, as is the increased use of precautionary and legal strategies in the post-HIV blood contamination era. Finally, consideration is given to a range of policy and legal strategies that should underpin effective risk governance involving multi-valued human biological materials.